I have spent most of 2015 highlighting in my Friday column small-cap stocks from the biotech and biopharma sectors that I find attractive, even if they are speculativeThese have included some big winners from my Best Ideas list such as Eagle Pharmaceuticals (EGRX) and Halozyme Therapeutics (HALO). We will look today at a promising small-cap, Navid...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.